Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarissa Corinaldesi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|August 23, 2024
MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesisChuanjiang Yu, Qiong Shen, Antony B Holmes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 3, 2017
Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cellsCristina Antinozzi, Clarissa Corinaldesi, Carla Giordano, et al.
Inflammation|May 12, 2016
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic CardiomyopathyLuigi Di Luigi, Clarissa Corinaldesi, Marta Colletti, et al.
Annals of the Rheumatic Diseases|February 5, 2021
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of sclerodermaRebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, et al.
Nature|October 17, 2022
Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphomaElodie Bal, Rahul Kumar, Mohammad Hadigol, et al.
Nature|July 6, 2022
Super-enhancer hypermutation alters oncogene expression in B cell lymphomaElodie Bal, Rahul Kumar, Mohammad Hadigol, et al.
Leukemia|October 18, 2024
Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistanceClarissa Corinaldesi, Antony B Holmes, Gaia Martire, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|August 23, 2024
MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesisChuanjiang Yu, Qiong Shen, Antony B Holmes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 3, 2017
Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cellsCristina Antinozzi, Clarissa Corinaldesi, Carla Giordano, et al.
Inflammation|May 12, 2016
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic CardiomyopathyLuigi Di Luigi, Clarissa Corinaldesi, Marta Colletti, et al.
Annals of the Rheumatic Diseases|February 5, 2021
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of sclerodermaRebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, et al.
Nature|October 17, 2022
Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphomaElodie Bal, Rahul Kumar, Mohammad Hadigol, et al.
Nature|July 6, 2022
Super-enhancer hypermutation alters oncogene expression in B cell lymphomaElodie Bal, Rahul Kumar, Mohammad Hadigol, et al.
Leukemia|October 18, 2024
Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistanceClarissa Corinaldesi, Antony B Holmes, Gaia Martire, et al.
Pageof 2